Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
2.41M
-
Shares change
-
+22.6K
-
Total reported value, excl. options
-
$161M
-
Value change
-
+$1.5M
-
Number of buys
-
59
-
Number of sells
-
-33
-
Price
-
$66.91
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q3 2024
117 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q3 2024.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.41M shares
of 3.2M outstanding shares and own 75.17% of the company stock.
Largest 10 shareholders include FMR LLC (269K shares), RENAISSANCE TECHNOLOGIES LLC (231K shares), VANGUARD GROUP INC (181K shares), BlackRock, Inc. (180K shares), DIMENSIONAL FUND ADVISORS LP (176K shares), BRANDES INVESTMENT PARTNERS, LP (138K shares), GEODE CAPITAL MANAGEMENT, LLC (97.1K shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (89K shares), Ranger Investment Management, L.P. (86.6K shares), and RICE HALL JAMES & ASSOCIATES, LLC (83.3K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.